4.7 Article

Molecular Genetics of Conjunctival Melanoma and Prognostic Value of TERT Promoter Mutation Analysis

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

Non-canonical roles of canonical telomere binding proteins in cancers

Semih Can Akincilar et al.

Summary: Telomerase activation is a common feature in cancer, but it does not directly correlate with telomere length. Aberrant expression of shelterin proteins and their release from shortened telomeres can further promote cancer through non-canonical mechanisms.

CELLULAR AND MOLECULAR LIFE SCIENCES (2021)

Article Ophthalmology

Prognostic value of TERT promoter mutations in conjunctival melanomas in addition to clinicopathological features

J. A. van Ipenburg et al.

Summary: The study evaluated prognostic factors in conjunctival melanomas (CM) and found that tumor characteristics like thickness, pT status, specific cell types, and mutations were correlated with metastasis. TERT promoter mutations were associated with shorter metastasis-free survival. Eyelid, fornix, and caruncular melanomas were more likely to recur. The majority of CM patients were treated with excision and adjuvant therapy.

BRITISH JOURNAL OF OPHTHALMOLOGY (2021)

Article Dermatology

Efficient Suppression of NRAS-Driven Melanoma by Co-Inhibition of ERK1/2 and ERK5 MAPK Pathways

Christian Adam et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2020)

Review Biochemistry & Molecular Biology

Genetic Biomarkers in Melanoma of the Ocular Region: What the Medical Oncologist Should Know

Kalijn Fredrike Bol et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Medicine, Research & Experimental

Pathology-based Biomarkers Useful for Clinical Decisions in Melanoma

Carlos Torres-Cabala et al.

ARCHIVES OF MEDICAL RESEARCH (2020)

Review Immunology

TERT-Regulation and Roles in Cancer Formation

Marta Dratwa et al.

FRONTIERS IN IMMUNOLOGY (2020)

Review Medicine, General & Internal

KIT and Melanoma: Biological Insights and Clinical Implications

Duc (Daniel) M. Pham et al.

YONSEI MEDICAL JOURNAL (2020)

Article Pathology

TERT gene: its function and dysregulation in cancer

Andrew J. Colebatch et al.

JOURNAL OF CLINICAL PATHOLOGY (2019)

Review Biochemistry & Molecular Biology

Conjunctival Melanoma: Genetic and Epigenetic Insights of a Distinct Type of Melanoma

Ernesto Rossi et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Oncology

NF1 mutations in conjunctival melanoma

S. L. Scholz et al.

BRITISH JOURNAL OF CANCER (2018)

Article Ophthalmology

Population-based incidence of conjunctival tumours in Olmsted County, Minnesota

Lauren A. Dalvin et al.

BRITISH JOURNAL OF OPHTHALMOLOGY (2018)

Review Medicine, General & Internal

Systemic treatments for metastatic cutaneous melanoma

Sandro Pasquali et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2018)

Article Pathology

Identification of recurrent mutational events in anorectal melanoma

Hui Min Yang et al.

MODERN PATHOLOGY (2017)

Article Ophthalmology

Conjunctival Melanoma in Chinese Patients: Local Recurrence, Metastasis, Mortality, and Comparisons With Caucasian Patients

Chuandi Zhou et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2017)

Review Ophthalmology

Systemic BRAF/MEK Inhibitors as a Potential Treatment Option in Metastatic Conjunctival Melanoma

Joel M. Mor et al.

OCULAR ONCOLOGY AND PATHOLOGY (2017)

Article Oncology

Rare SF3B1 R625 mutations in cutaneous melanoma

Yong Kong et al.

MELANOMA RESEARCH (2014)

Review Ophthalmology

Management of conjunctival malignant melanoma: a review and update

James R. Wong et al.

EXPERT REVIEW OF OPHTHALMOLOGY (2014)

Editorial Material Medicine, Research & Experimental

The role of BRAF V600 mutation in melanoma

Paolo A. Ascierto et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2012)

Article Oncology

Clinical Correlates of NRAS and BRAF Mutations in Primary Human Melanoma

Julie A. Ellerhorst et al.

CLINICAL CANCER RESEARCH (2011)

Article Medicine, General & Internal

Mutations in GNA11 in Uveal Melanoma.

Catherine D. Van Raamsdonk et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Ophthalmology

Mortality after uveal and conjunctival melanoma: which tumour is more deadly?

Emma Kujala et al.

ACTA OPHTHALMOLOGICA (2009)

Article Ophthalmology

Time trends in the incidence of conjunctival melanoma in Sweden

E. Triay et al.

BRITISH JOURNAL OF OPHTHALMOLOGY (2009)

Article Ophthalmology

Conjunctival melanoma in the Netherlands: A nationwide study

GS Missotten et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2005)